Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Chi

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Science (New York, N.Y.)|May 14, 2016
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscapeChao Lu, Siddhant U Jain, Dominik Hoelper, et al.
Cancer Research Communications|December 1, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated LiposarcomaEvan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.
Nature|October 8, 2015
Alternative transcription initiation leads to expression of a novel ALK isoform in cancerThomas Wiesner, William Lee, Anna C Obenauf, et al.
Nature Communications|June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcomaSandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
JCO Oncology Advances|May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in SarcomaEvan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, et al.
Cancer Cell|February 5, 2021
Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated LiposarcomaCaroline E Gleason, Mark A Dickson, Mary E Klein Dooley, et al.
Cell|September 10, 2014
Organoid cultures derived from patients with advanced prostate cancerDong Gao, Ian Vela, Andrea Sboner, et al.
JCO Precision Oncology|September 12, 2017
OncoKB: A Precision Oncology Knowledge BaseDebyani Chakravarty, Jianjiong Gao, Sarah M Phillips, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Science (New York, N.Y.)|May 14, 2016
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscapeChao Lu, Siddhant U Jain, Dominik Hoelper, et al.
Cancer Research Communications|December 1, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated LiposarcomaEvan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.
Nature|October 8, 2015
Alternative transcription initiation leads to expression of a novel ALK isoform in cancerThomas Wiesner, William Lee, Anna C Obenauf, et al.
Nature Communications|June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcomaSandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
JCO Oncology Advances|May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in SarcomaEvan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, et al.
Cancer Cell|February 5, 2021
Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated LiposarcomaCaroline E Gleason, Mark A Dickson, Mary E Klein Dooley, et al.
Cell|September 10, 2014
Organoid cultures derived from patients with advanced prostate cancerDong Gao, Ian Vela, Andrea Sboner, et al.
JCO Precision Oncology|September 12, 2017
OncoKB: A Precision Oncology Knowledge BaseDebyani Chakravarty, Jianjiong Gao, Sarah M Phillips, et al.
Pageof 27